Begin main content

Reports

We found 6672 result(s)

upadacitinib (Rinvoq)

Last Updated: January 28, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: upadacitinib
Indications: Arthritis, Rheumatoid

  • Brand Name: Rinvoq
  • Manufacturer: AbbVie
  • Project Number: SR0614-000
  • Project Status: Active
  • Submission Type: New

Halobetasol propionate and tazarotene (Duobrii)

Last Updated: January 27, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: Halobetasol propionate and tazarotene
Indications: Psoriasis, moderate to severe plaque

  • Brand Name: Duobrii
  • Manufacturer: Bausch Health, Canada Inc.
  • Project Number: SR0638-000
  • Project Status: Received
  • Submission Type: New Combination

In Brief: Genome-Wide Sequencing for Unexplained Developmental Delays and Multiple Congenital Anomalies

Last Updated: January 27, 2020
Result type: Tools
Product Line: Rapid Response

Key Messages Families and clinicians see genome-wide sequencing (a form of genetic testing) as a valuable tool for potentially determining the cause of a child’s unexplained condition (e.g., developmental delays or congenital anomalies). Knowing the cause, or causes, of their child’s condition can provide families with an initial sense of rel...

  • Project Number: HE0020-000

Files

2020 CADTH Symposium Registration is now open

Published on: January 27, 2020
Result type: News

Connect with Canadian and international experts in the objective assessment and evaluation of health technologies this April in Toronto, Ontario. We have added an additional full day of thought-provoking and interactive workshops to the program for a total of four days of education, information sharing, and networking. Please note: Anyone can...

eculizumab (Soliris)

Last Updated: January 24, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: eculizumab
Indications: Neuromyelitis optica spectrum disorder

  • Brand Name: Soliris
  • Manufacturer: Alexion Pharma Canada Corp.
  • Project Number: SR0640-000
  • Project Status: Pending
  • Submission Type: New Indication

glucagon (Baqsimi)

Last Updated: January 24, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: glucagon
Indications: Severe hypoglycemic reactions

  • Brand Name: Baqsimi
  • Manufacturer: Eli Lilly Canada Inc.
  • Project Number: SR0626-000
  • Project Status: Active
  • Submission Type: New

caplacizumab (Cablivi)

Last Updated: January 24, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: caplacizumab
Indications: Acquired thrombotic thrombocytopenic purpura (aTTP)

  • Brand Name: Cablivi
  • Manufacturer: Sanofi-Genzyme, a division of sanofi-aventis Canada Inc.
  • Project Number: SR0633-000
  • Project Status: Active
  • Submission Type: New

budesonide (Jorveza)

Last Updated: January 24, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: budesonide
Indications: Eosinophilic esophagitis, adults

  • Brand Name: Jorveza
  • Manufacturer: AVIR Pharma Inc.
  • Project Number: SR0634-000
  • Project Status: Active
  • Submission Type: New

apomorphine hydrochloride (Kynmobi)

Last Updated: January 23, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: apomorphine hydrochloride
Indications: Parkinson’s Disease

  • Brand Name: Kynmobi
  • Manufacturer: Sunovion Pharmaceuticals Canada Inc.
  • Project Number: SR0604-000
  • Project Status: Withdrawn
  • Submission Type: New